The Current Ratio of Kiniksa Pharmaceuticals International, PLC (KNSA) is
3.79.
Current Ratio compares a firm's current assets to its current liabilities to assess short-term liquidity. A ratio above 1.0 typically indicates a strong ability to meet obligations.
| Date |
Value |
| 2025-12-31 |
3.79
|
| 2024-12-31 |
3.30
|
| 2023-12-31 |
4.34
|
| 2022-12-31 |
5.16
|
| 2021-12-31 |
4.38
|
| 2020-12-31 |
10.48
|
| 2019-12-31 |
8.69
|
| 2018-12-31 |
7.37
|
| 2017-12-31 |
2.71
|
| 2016-12-31 |
24.48
|
| Ticker |
Name |
Value |
|
ANNX
|
Annexon, Inc.
|
5.68
|
|
CRTX
|
Cortexyme Inc
|
7.85
|
|
PASG
|
Passage Bio Inc
|
2.07
|
|
PRAX
|
Praxis Precision Medicines, Inc.
|
10.22
|
|
PRTA
|
Prothena Corporation PLC
|
7.72
|
|
CYDY
|
Cytodyn Inc
|
0.26
|
|
MRSN
|
Mersana Therapeutics Inc
|
2.19
|
|
NWBO
|
Northwest Biotherapeutics Inc
|
0.06
|
|
TRIL.TO
|
Trillium Therapeutics Inc
|
13.95
|
|
CMPS
|
Compass Pathways PLC
|
0.77
|
|
RYTM
|
Rhythm Pharmaceuticals, Inc.
|
4.41
|
|
SNDX
|
Syndax Pharmaceuticals, Inc.
|
4.40
|
|
ADVM
|
Adverum Biotechnologies Inc
|
5.73
|
|
KROS
|
Keros Therapeutics, Inc.
|
15.45
|
|
TSHA
|
Taysha Gene Therapies, Inc.
|
12.23
|
|
ARCT
|
Arcturus Therapeutics Holdings Inc
|
6.64
|
|
AVXL
|
Anavex Life Sciences Corp
|
11.60
|
|
BTAI
|
BioXcel Therapeutics Inc
|
0.83
|
|
DVAX
|
Dynavax Technologies Corp
|
10.80
|
|
EPIX
|
ESSA Pharma Inc
|
38.79
|
|
PCVX
|
Vaxcyte, Inc.
|
7.91
|
|
AFMD
|
Affimed NV
|
3.25
|
|
ATRA
|
Atara Biotherapeutics, Inc.
|
0.82
|
|
AKRO
|
Akero Therapeutics Inc
|
19.25
|
|
ALGS
|
Aligos Therapeutics, Inc.
|
3.90
|
|
FDMT
|
4D Molecular Therapeutics Inc
|
9.39
|
|
ITOS
|
iTeos Therapeutics Inc
|
12.75
|
|
ORIC
|
ORIC Pharmaceuticals, Inc.
|
14.13
|